Session » Systemic Sclerosis & Related Disorders – Basic Science Poster (0541–0559)
- 8:30AM-10:30AM
-
Abstract Number: 0547
Autologous Haematopoietic Stem Cell Transplantation for Systemic Sclerosis Results in Sustained Changes in Immunoregulatory T and NK Cells
- 8:30AM-10:30AM
-
Abstract Number: 0542
Functional Characterization of Glycoprotein Nonmetastatic Melanoma Protein B in Scleroderma Fibrosis
- 8:30AM-10:30AM
-
Abstract Number: 0553
IgG from Systemic Sclerosis Patients Induce a Profibrosing and Serotype-dependent Phenotype in Normal Dermal Fibroblast: A Multi-omics Study
- 8:30AM-10:30AM
-
Abstract Number: 0546
Integrated Analysis of Dermal Blister Fluid Proteomics and Genome-wide Skin Gene Expression Gives New Insight into Pathogenesis of Systemic Sclerosis
- 8:30AM-10:30AM
-
Abstract Number: 0556
Investigating the Heterogeneity of Skin Macrophages in Systemic Scleroderma
- 8:30AM-10:30AM
-
Abstract Number: 0552
Long Non-coding RNA H19X as a Regulator of Endothelial Adhesion Molecules in Systemic Sclerosis
- 8:30AM-10:30AM
-
Abstract Number: 0551
Metabolic Intermediate Dimethyl-Alpha-Ketoglutarate Is a Novel Repressor of Pathogenic Myofibroblast Reprogramming and Skin Fibrosis in Systemic Sclerosis
- 8:30AM-10:30AM
-
Abstract Number: 0541
N-formyl Methionine Peptide-mediated Neutrophil Activation in Systemic Sclerosis
- 8:30AM-10:30AM
-
Abstract Number: 0543
Novel Insights into Systemic Sclerosis Using a Sensitive Computational Method to Analyze Whole-genome Bisulfite Sequencing Data
- 8:30AM-10:30AM
-
Abstract Number: 0555
Pathway-Driven Drug Repositioning in Systemic Sclerosis from Omics Data
- 8:30AM-10:30AM
-
Abstract Number: 0548
Rapamycin Blocks the Profibrotic Effects of Fli1 Downregulation in Scleroderma Myeloid Cells
- 8:30AM-10:30AM
-
Abstract Number: 0554
Reverse Signaling Through PD-L1 Plays a Central Role in Extracellular Matrix Protein Secretion from Cutaneous Myofibroblasts in Systemic Sclerosis
- 8:30AM-10:30AM
-
Abstract Number: 0545
SIRT1 Modulates the Senescent Phenotype in Scleroderma Endothelial Cells
- 8:30AM-10:30AM
-
Abstract Number: 0544
Targeting CD13/aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis
- 8:30AM-10:30AM
-
Abstract Number: 0559
Targeting NNMT as a Novel Metabolic Approach to Treat Systemic Sclerosis
- 8:30AM-10:30AM
-
Abstract Number: 0557
The Beta Secretase BACE1 Induces Systemic Sclerosis (SSc) Fibroblast Activation Through the Regulation of the Pro-Fibrotic Notch Signalling Pathway
- 8:30AM-10:30AM
-
Abstract Number: 0558
The Systemic Sclerosis (SSc) Risk Gene A20 (TNFAIP3) and Its Repressor DREAM Determine Susceptibility to Fibrosis
- 8:30AM-10:30AM
-
Abstract Number: 0550
Treatment Regimens and Outcomes in Systemic Sclerosis-associated Pulmonary Arterial Hypertension
- 8:30AM-10:30AM
-
Abstract Number: 0549
Upregulation of Prostanoid EP2 Receptors and Meditation of Treprostinil Anti-Proliferative Effects in Scleroderma Smooth Muscle Cells